有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。
The spines of sea urchins can generate a voltage when water moves around them — a phenomenon that could be used to design underwater flow sensors.
，更多细节参见搜狗输入法2026
Samsung Galaxy S26 vs. S24: After comparing both models, here's my take
한동훈 “백의종군 하라? 그분들, 尹이 보수 망칠때 뭐했나”